Rejuvel Bio-sciences (NUUU) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access NUUU Annual Balance Sheets →
Examining balance sheet movements between Rejuvel Bio-sciences and Sep 30 2014 reveals how Sep 30 2015 adjusts its asset composition and liability profile.
Quarterly Report, GAAP in USD millions
ITEM
(Sep 30 2015)
(Jun 30 2015) (Mar 31 2015) (Dec 31 2014) (Sep 30 2014)
Assets
Cash & cash equivalent0.00
Cash, Cash Equivalents Other0.01
Cash & Short-term Investments0.00
Accounts receivable0.00
Inventories0.03
Other Current Assets0.05
Total Current Assets0.09
Equipment/Property/Plant Net0.00
Intangible Assets0.01
Other Assets, Noncurrent0.03
Total Assets0.13
Liabilities
Accounts Payable and Accrued Liabilities, Current LI0.60
Derivative Liability, Current DE0.47
Notes Payable, Current NO0.00
Other Liabilities, Current0.63
Deferred Rent Credit, Current DE0.00
Total Current Liabilities1.70
Long-term debt0.01
Long-term Debt Convertible0.19
Total Long-term Debt0.20
Total Liabilities1.71
Stockholders' Equity
Common Stock Value0.05
Additional Paid In Capital Common Stock1.73
Retained Earnings / Accumulated Deficit-3.36
Other Equity0.00
Common Stockholder's Equity-1.57
Total Stockholder's Equity-1.57
Liabilities & Stockholder's Equity0.13
4 historic quarters locked

Sign in to unlock the full Rejuvel Bio-sciences balance sheet history.

About NUUU Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-Q
  • Filed with the SEC: n/a

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.